Johnson & Johnson has asked a federal district court to expedite its decision in a case over the company’s proposed 340B ...

Robert F. Kennedy Jr. advances toward Senate confirmation despite vaccine controversy, as key skeptic Sen. Bill Cassidy backs ...

At long last, the FDA approved Supernus Pharmaceuticals’ Parkinson’s disease treatment, which will be marketed as Onapgo.

China tensions, following US restrictions on Chinese rivals BGI and MGI. Illumina says China accounts for 7% of Q3 revenue.

Bicycle Health, a telehealth provider for opioid use disorder treatment led by Ankit Gupta, turns profitable and raises ...

Astellas is reorganizing its management team, and while it doesn't involve a change at the top as Daiichi Sankyo announced ...

Despite uncertainty around HPV vaccine sales in China, Merck CEO Robert Davis said he’s confident the company can “deliver strong growth” and navigate Keytruda’s impending patent cliff.

Alzheimer’s disease has afflicted Hannah Richardson’s family for generations. A rare genetic mutation, passed down from her ...

Bavarian Nordic’s stock dropped around 10% on the Danish stock exchange Tuesday after reporting disappointing 2024 sales ...

Regeneron Pharmaceuticals, one of the original and longest-standing biotech companies, is entering the dividends arena for ...

Pfizer said Tuesday it raked in $63.6 billion in 2024, close to the top end of its guidance, and reaffirmed its sales goal ...

Omega Therapeutics anticipates filing for bankruptcy within the next week, the epigenomic medicines company said in a filing.